Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
From fine-tuning open source models to building agentic frameworks on top of them, the open source world is ripe with ...